Cargando…

2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD

BACKGROUND: Steroid refractory acute graft- vs. -host-disease (GVHD) after hematopoietic cell transplantation (HCT) is highly morbid with limited treatment options. Murine studies show protection from GVHD with butyrate exposure but direct exposure of stem/progenitor cells to butyrate inhibits colon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golob, Jonathan L, DeMeules, Martha M, Loeffelholz, Tillie, Quinn, Z Z, Dame, Michael K, Silvestri, Sabrina, Wu, Michael, Schmidt, Tom, Fiedler, Tina L, Hoostal, Matthew, Mielcarek, Marco, Spence, Jason, Pergam, Steven A, Fredricks, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808863/ http://dx.doi.org/10.1093/ofid/ofz359.149

Ejemplares similares

Stool Microbiota at Neutrophil Recovery Is Predictive for Severe Acute Graft vs Host Disease After Hematopoietic Cell Transplantation
por: Golob, Jonathan L, et al.
Publicado: (2017)

Measuring the completeness of death registration in 2844 Chinese counties in 2018
por: Zeng, Xinying, et al.
Publicado: (2020)

Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease
por: Cantu-Jungles, Thaisa M., et al.
Publicado: (2019)

2844. Impact of Altered Mental Status on Antibiotic Prescribing in Patients with Pyuria
por: Boerckel, Haley, et al.
Publicado: (2023)

1076. Gaps in Measles and Mumps Seroprevalence Among Cancer Patients
por: Marquis, Sara, et al.
Publicado: (2020)

Genomic assessment in Lactobacillus plantarum links the butyrogenic pathway with glutamine metabolism
por: Botta, Cristian, et al.
Publicado: (2017)

Absolute Enumeration of Probiotic Strains Lactobacillus acidophilus NCFM(®) and Bifidobacterium animalis subsp. lactis Bl-04(®) via Chip-Based Digital PCR
por: Hansen, Sarah J. Z., et al.
Publicado: (2018)

Steroid-Refractory Acute GVHD: Predictors and Outcomes
por: Westin, Jason R., et al.
Publicado: (2011)

Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer
por: Marquis, Sara R., et al.
Publicado: (2021)

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
por: Herzog, Shannon, et al.
Publicado: (2023)

The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant
por: Devaux, Christian Albert, et al.
Publicado: (2020)

Colonisation of the colonic mucus gel layer with butyrogenic and hydrogenotropic bacteria in health and ulcerative colitis
por: Earley, Helen, et al.
Publicado: (2021)

Exogenous butyrate inhibits butyrogenic metabolism and alters expression of virulence genes in Clostridioides difficile
por: Pensinger, Daniel A., et al.
Publicado: (2023)

Gender essentialism in transgender and cisgender children
por: Gülgöz, Selin, et al.
Publicado: (2019)

616. Vancomycin Is Frequently Administered to Hematopoietic Cell Transplant Recipients Without a Provider Documented Indication and Correlates with Microbiome Disruption and Adverse Events
por: Golob, Jonathan, et al.
Publicado: (2018)

Bifidogenic and butyrogenic effects of young barely leaf extract in an in vitro human colonic microbiota model
por: Sasaki, Daisuke, et al.
Publicado: (2019)

Deciphering the trophic interaction between Akkermansia muciniphila and the butyrogenic gut commensal Anaerostipes caccae using a metatranscriptomic approach
por: Chia, Loo Wee, et al.
Publicado: (2018)

Selective induction of human gut-associated acetogenic/butyrogenic microbiota based on specific microbial colonization of indigestible starch granules
por: Nagara, Yusuke, et al.
Publicado: (2022)

Long-Term Use of Ruxolitinib in an AML Patient with Posttransplant Steroid Refractory GVHD
por: Sobash, Philip T., et al.
Publicado: (2020)

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
por: Hildebrandt, G C, et al.
Publicado: (2011)

Analysis of Antibiotic Exposure and Development of Acute Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
por: Rashidi, Armin, et al.
Publicado: (2023)

Spatiotemporal trends and ecological determinants of cardiovascular mortality among 2844 counties in mainland China, 2006–2020: a Bayesian modeling study of national mortality registries
por: Wang, Wei, et al.
Publicado: (2022)

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation
por: Ueda Oshima, Masumi, et al.
Publicado: (2023)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

Systematic review and meta-analysis of prospective studies for ECP treatment in patients with steroid-refractory acute GVHD
por: Zhang, Hongming, et al.
Publicado: (2015)

Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD
por: Baek, Dong Won, et al.
Publicado: (2022)

Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD
por: Liu, Yin, et al.
Publicado: (2022)

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
por: Weng, J Y, et al.
Publicado: (2010)

Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD
por: Buxbaum, Nataliya P., et al.
Publicado: (2022)

Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases
por: Wernicke, Caroline M, et al.
Publicado: (2011)

Inflammasome effects in GvHD
por: Koehn, Brent H., et al.
Publicado: (2015)

Targeting Cytokines in GVHD Therapy
por: Kumar, Sandeep, et al.
Publicado: (2017)

Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022)

Regulatory T Cells in GVHD Therapy
por: Guo, Wen-wen, et al.
Publicado: (2021)

Milestones in acute GVHD pathophysiology
por: Socie, Gerard, et al.
Publicado: (2022)

Utility of eGVHD App for bedside GVHD assessment in a high-volume BMT center
por: Chhabra, Prashant, et al.
Publicado: (2023)

Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
por: Maurer, Katie, et al.
Publicado: (2023)

Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials
por: Luo, Chengxin, et al.
Publicado: (2023)

Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium
por: DeFilipp, Zachariah, et al.
Publicado: (2021)

Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy
por: Yang, Jingjing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lmnf9fnotpjntd45dgreq2mkfm